Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose prednisolone vs anti-TNF in MTX-inadequate responder RA
NCT01724268Phase 3Unknown
- Sponsor
- Hamad Medical Corporation
- Start
- May 2012
- Primary completion
- May 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of prednisolone in rheumatoid arthritis (RA), sponsored by Hamad Medical Corporation. Status: unknown.
02
Drugs
prednisolone
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01724268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01724268.